Marc Becker
2021 - Concert Pharmaceuticals
In 2021, Marc Becker earned a total compensation of $1.4M as Chief Financial Officer at Concert Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $238,942 |
|---|---|
| Option Awards | $415,241 |
| Salary | $428,595 |
| Stock Awards | $283,619 |
| Other | $9,510 |
| Total | $1,375,907 |
Becker received $428.6K in salary, accounting for 31% of the total pay in 2021.
Becker also received $238.9K in non-equity incentive plan, $415.2K in option awards, $283.6K in stock awards and $9.5K in other compensation.
Rankings
In 2021, Marc Becker's compensation ranked 7,612th out of 12,415 executives tracked by ExecPay. In other words, Becker earned more than 38.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,612 out of 12,415 | 39th |
Division Manufacturing | 3,351 out of 5,505 | 39th |
Major group Chemicals And Allied Products | 1,485 out of 2,375 | 38th |
Industry group Drugs | 1,321 out of 2,096 | 37th |
Industry Pharmaceutical Preparations | 975 out of 1,546 | 37th |
Source: SEC filing on April 26, 2022.
Becker's colleagues
We found two more compensation records of executives who worked with Marc Becker at Concert Pharmaceuticals in 2021.